A 70-year-old woman is discharged after nonsevere CDI treated with fidaxomicin. She has multiple recurrence risk factors. Which adjunct could reduce r...

Question

A 70-year-old woman is discharged after nonsevere CDI treated with fidaxomicin. She has multiple recurrence risk factors. Which adjunct could reduce recurrence?

Accepted Answer

Bezlotoxumab infusion during antibiotic course

Answer

Prophylactic metronidazole

Answer

Probiotics indefinitely

Answer

Cholestyramine daily

Answer

No recurrence strategies exist

us-abim MCQ (SBA): C. difficile-Bezlotoxumab

A 70-year-old woman is discharged after nonsevere CDI treated with fidaxomicin. She has multiple recurrence risk factors. Which adjunct could reduce recurrence?